Abstract
Recently developed immunotherapies and targeted therapies have largely replaced chemotherapy for treatment of patients with metastatic and nonresectable melanoma. These new drugs have improved the prognosis for many patients, but GPs need to be aware of their unique toxicities.
| Original language | English |
|---|---|
| Pages (from-to) | 58-61 |
| Number of pages | 4 |
| Journal | Medicine Today |
| Volume | 16 |
| Issue number | 9 |
| Publication status | Published - 1 Jan 2015 |
| Externally published | Yes |
Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver